CAS 1020567-30-9

Fórmula: C29H22Cl2N2O4

InChI: InChI=1S/C29H22Cl2N2O4/c1-16(2)28-21(27(33-37-28)26-22(30)4-3-5-23(26)31)15-36-20-10-6-17(7-11-20)18-8-12-24-19(14-18)9-13-25(32-24)29(34)35/h3-14,16H,15H2,1-2H3,(H,34,35)

Clave InChI: SZUHDKKQQZPOGX-UHFFFAOYSA-N

SMILES: CC(C)C1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)COC3=CC=C(C=C3)C4=CC5=C(C=C4)N=C(C=C5)C(=O)O

GSK2324

CAS: 1020567-30-9

GSK2324

Fórmula: C₂₉H₂₂Cl₂N₂O₄

Pureza: ≥98%

Peso molecular: 533.4

Ref: 54-BUP07950

GSK2324

CAS: 1020567-30-9

Fórmula: C₂₉H₂₂Cl₂N₂O₄

Peso molecular: 533.402

Ref: IN-DA023IK1

GSK2324

CAS: 1020567-30-9

GSK2324 is a potent FXR agonist for the treatment of NAFLD by controlling hepatic lipids through reduced uptake and selective reduction of fatty acid synthesis.

Fórmula: C₂₉H₂₂Cl₂N₂O₄

Pureza: 98.09% - 99.76%

Forma y color: Solid

Peso molecular: 533.402

Ref: TM-T27460